Edgewise Therapeutics, Inc. (EWTX) SEC filings
EWTX SEC filings moved a median of +0.08% by the close. EWTX SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the EWTX overview →
55 measured EWTX SEC filing events.
Where these EWTX SEC filings landedvs 55 measured EWTX SEC filing reactions
| Middle 50% of EWTX SEC filing reactions | -3.22% to +1.78% |
|---|---|
| Median reaction (to close) | +0.08% |
| Measured reactions | 55 |
Point-in-time · zero look-ahead
Half of the 55 EWTX SEC filing events with a measured close landed between -3.22% and +1.78%; 51% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Edgewise Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +0.79% | +0.66% | |
| Form 8-K Edgewise Therapeutics, For: Aug 06 | SEC filing · Form 8-K | +0.79% | +0.66% | |
| Form 8-K/A Edgewise Therapeutics, For: Jul 10 | SEC filing · Form 8-K | -1.18% | -5.82% | |
| Form 8-K Edgewise Therapeutics, For: Jul 10 | SEC filing · Form 8-K | -2.77% | -6.90% | |
| Form 8-K Edgewise Therapeutics, For: Jun 04 | SEC filing · Form 8-K | +2.41% | -1.86% | |
| Form 8-K Edgewise Therapeutics, For: May 31 | SEC filing · Form 8-K | -3.83% | -0.84% | |
| Form 10-Q Edgewise Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -3.97% | -6.37% | |
| Form 8-K Edgewise Therapeutics, For: May 07 | SEC filing · Form 8-K | -3.97% | -6.37% | |
| Form S-8 Edgewise Therapeutics, | SEC filing · Form S-8 | +0.22% | -0.09% | |
| Form ARS Edgewise Therapeutics, For: Dec 31 | SEC filing · Form ARS | -1.03% | +0.57% | |
| Form DEF 14A Edgewise Therapeutics, For: Jun 04 | SEC filing · Form DEF | -1.03% | +0.57% | |
| Form DEFA14A Edgewise Therapeutics, | SEC filing · Form DEFA14A | -1.03% | +0.57% | |
| Form 10-K Edgewise Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -1.57% | -0.80% | |
| Form 8-K Edgewise Therapeutics, For: Feb 26 | SEC filing · Form 8-K | -1.57% | -0.80% | |
| Form 8-K Edgewise Therapeutics, For: Nov 19 | SEC filing · Form 8-K | -2.16% | +2.12% | |
| Form 8-K Edgewise Therapeutics, For: Nov 10 | SEC filing · Form 8-K | +0.44% | +17.50% | |
| Form 10-Q Edgewise Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -0.17% | -2.84% | |
| Form 8-K Edgewise Therapeutics, For: Nov 06 | SEC filing · Form 8-K | -0.17% | -2.84% | |
| Form 10-Q Edgewise Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -2.23% | -6.90% | |
| Form 8-K Edgewise Therapeutics, For: Aug 07 | SEC filing · Form 8-K | -2.23% | -6.90% | |
| Form 8-K Edgewise Therapeutics, For: Jun 26 | SEC filing · Form 8-K | -0.28% | +0.08% | |
| Form DEFA14A Edgewise Therapeutics, | SEC filing · Form DEFA14A | -1.72% | -0.82% | |
| Form 10-Q Edgewise Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +1.15% | +1.31% | |
| Form 8-K Edgewise Therapeutics, For: May 08 | SEC filing · Form 8-K | +1.15% | +1.31% | |
| Form DEF 14A Edgewise Therapeutics, For: Jun 13 | SEC filing · Form DEF | -1.54% | +5.47% | |
| Form DEFA14A Edgewise Therapeutics, | SEC filing · Form DEFA14A | -1.54% | +5.47% | |
| Form 8-K Edgewise Therapeutics, For: Apr 02 | SEC filing · Form 8-K | -11.52% | +7.03% | |
| Form 10-K Edgewise Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +2.17% | -1.01% | |
| Form 8-K Edgewise Therapeutics, For: Mar 03 | SEC filing · Form 8-K | +2.17% | -1.01% | |
| Form S-8 Edgewise Therapeutics, | SEC filing · Form S-8 | +0.74% | -2.47% | |
| Form 8-K Edgewise Therapeutics, For: Jan 08 | SEC filing · Form 8-K | +2.69% | +4.14% | |
| Form 8-K Edgewise Therapeutics, For: Dec 16 | SEC filing · Form 8-K | -0.87% | -9.59% | |
| Form 10-Q Edgewise Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -0.68% | -3.59% | |
| Form 8-K Edgewise Therapeutics, For: Nov 07 | SEC filing · Form 8-K | -0.68% | -3.59% | |
| Form S-8 Edgewise Therapeutics, | SEC filing · Form S-8 | -0.68% | -3.59% | |
| Form 8-K Edgewise Therapeutics, For: Aug 10 | SEC filing · Form 8-K | +0.26% | +0.41% | |
| Form 10-Q Edgewise Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -0.75% | +1.70% | |
| Form 8-K Edgewise Therapeutics, For: Aug 08 | SEC filing · Form 8-K | -0.75% | +1.70% | |
| Form 8-K Edgewise Therapeutics, For: Jun 07 | SEC filing · Form 8-K | +0.39% | +1.79% | |
| Form 8-K Edgewise Therapeutics, For: May 10 | SEC filing · Form 8-K | +1.48% | -5.03% | |
| Form S-3ASR Edgewise Therapeutics, | SEC filing · Form S-3ASR | +1.48% | -5.03% | |
| Form 10-Q Edgewise Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +5.19% | +1.78% | |
| Form 8-K Edgewise Therapeutics, For: May 09 | SEC filing · Form 8-K | +5.19% | +1.78% | |
| Form S-8 Edgewise Therapeutics, | SEC filing · Form S-8 | +5.19% | +1.78% | |
| Form 8-K Edgewise Therapeutics, For: May 06 | SEC filing · Form 8-K | +0.64% | +4.22% | |
| Form DEFA14A Edgewise Therapeutics, | SEC filing · Form DEFA14A | +0.64% | +4.22% | |
| Form DEF 14A Edgewise Therapeutics, For: Jun 07 | SEC filing · Form DEF | +1.47% | +4.47% | |
| Form DEFA14A Edgewise Therapeutics, | SEC filing · Form DEFA14A | +1.47% | +4.47% | |
| Form PRE 14A Edgewise Therapeutics, For: Jun 07 | SEC filing · Form PRE | -2.03% | +2.15% | |
| Form 10-K Edgewise Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +0.74% | -0.80% | |
| Form 8-K Edgewise Therapeutics, For: Feb 22 | SEC filing · Form 8-K | +0.74% | -0.80% | |
| Form 8-K Edgewise Therapeutics, For: Jan 19 | SEC filing · Form 8-K | +1.38% | +5.93% | |
| Form S-3MEF Edgewise Therapeutics, | SEC filing · Form S-3MEF | +1.38% | +5.93% | |
| Form 10-Q Edgewise Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -2.87% | -8.77% | |
| Form 8-K Edgewise Therapeutics, For: Nov 09 | SEC filing · Form 8-K | -2.87% | -8.77% |
Keep exploring
More EWTX: earnings → · analyst actions → · EWTX overview →